CytomX Therapeutics, Inc 10-K for FY2025
CytomX Therapeutics, Inc. (CTMX)
10-K
2026-03-16
For: 2025-12-31
View Original
Added on
April 09, 2026
About this 10-K
CytomX Therapeutics, Inc filed this 10-K on March 16, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $76.2M
- down 44.8% from $138.1M a year earlier
- Net loss
- $17.37M
- compared with net income of $31.87M a year earlier